DIMENSIONAL FUND ADVISORS LP

Position in TBPH — Theravance Biopharma, Inc.

CIK 354204 AUSTIN, TX

Position in TBPH

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$17,731,867

+$1,767,798 QoQ

Shares Held

1,043,051

+6.0% QoQ

Ownership

2.01%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#12

of 179 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 91% Shared 5% None 4%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. TBPH ranks #61 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,731,867	1,043,051	+6.0%	Shares	Sole	2026-08-11
2026-03-31	$15,964,069	983,615	+14.5%	Shares	Sole	2026-05-07
2025-12-31	$16,071,083	858,957	+12.0%	Shares	Sole	2026-02-12
2025-09-30	$11,193,877	766,704	+6.2%	Shares	Sole	2025-11-12
2025-06-30	$7,964,429	722,070	+12.2%	Shares	Sole	2025-08-12
2025-03-31	$5,749,471	643,838	+16.3%	Shares	Sole	2025-05-13
2024-12-31	$5,210,437	553,713	+20.8%	Shares	Sole	2025-02-13
2024-09-30	$3,694,774	458,409	+38.8%	Shares	Defined	2024-11-07
2024-06-30	$2,799,934	330,181	+38.4%	Shares	Sole	2024-08-09
2024-03-31	$2,139,361	238,502	+79.1%	Shares	Sole	2024-05-10
2023-12-31	$1,496,987	133,184	+86.0%	Shares	Sole	2024-02-07
2023-09-30	$618,079	71,620	+0.0%	Shares	Sole	2023-11-09
2023-06-30	$741,101	71,604	—	Shares	Sole	2023-08-09
No filing history on record for this holder in this stock.